Khemla, S., Meesing, A., Sribenjalux, W. and Chetchotisakd, P. (2023) “Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir”, Drug Target Insights, 17(1), pp. 45–53. doi: 10.33393/dti.2023.2529.